Differential loss of expression of common fragile site genes between oral tongue and oropharyngeal squamous cell carcinomas

Cytogenetic and Genome Research

Volumn 121, Issue 3-4, 2008, Pages 201-210

  Soderberg, C ^a   Perez, D S ^a   Ukpo, O C ^a   Liang, X ^a,b   O'Reilly, A G ^a   Moore, E J ^a   Kademani, D ^a   Smith, D I ^a  

^a Mayo Clinic College of Medicine   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME FRAGILE SITE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHROMOSOME FRAGILE SITES; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TONGUE NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 50849091602     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000138886     Document Type: Article

References (64)

1. Arlt MF, Casper AM, Glover TW: Common fragile sites. Cytogenet Genome Res 100:92-100 (2003).
2. Arlt MF, Durkin SG, Ragland RL, Glover TW: Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst) 5:1126-1135 (2006).
3. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, et al: Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477 (1991).
4. Becker NA, Thorland EC, Denison SR, Phillips LA, Smith DI: Evidence that instability within the FRA3B region extends four megabases. Oncogene 21:8713-8722 (2002).
5. Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI: Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 22:590-601 (2003).
6. Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, et al: Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci USA 100:5956-5961 (2003).
7. Chang NS, Doherty J, Ensign A, Lewis J, Heath J, et al: Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses. Biochem Pharmacol 66:1347-1354 (2003).
8. Chen JK, Katz RV, Krutchkoff DJ: Intraoral squamous cell carcinoma. Epidemiologic patterns in Connecticut from 1935 to 1985. Cancer 66:1288-1296 (1990).
9. Cox C, Bignell G, Greenman C, Stabenau A, Warren W, et al: A survey of homozygous deletions in human cancer genomes. Proc Natl Acad Sci USA 102:4542-4547 (2005).
10. Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, et al: Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 112:1015-1019 (2004).
11. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ: The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062 (1995).
12. Denison SR, Callahan G, Becker NA, Phillips LA, Smith DI: Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer 38:40-52 (2003).
13. Dumon KR, Ishii H, Fong LY, Zanesi N, Fidanza V, et al: FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc Natl Acad Sci USA 98:3346-3351 (2001).
14. Durkin SG, Ragland RL, Arlt MF, Mulle JG, Warren ST, Glover TW: Replication stress induces tumor-like microdeletions in FHIT/FRA3B . Proc Natl Acad Sci USA 105:246-251 (2008).
15. Fabbri M, Iliopoulos D, Trapasso F, Aqeilan RI, Cimmino A, et al: WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci USA 102:15611-15616 (2005).
16. Gillison ML, Shah KV: Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 13:183-188 (2001).
17. Glover TW: Instability at chromosomal fragile sites. Recent Results Cancer Res 154:185-199 (1998).
18. Glover TW: Common fragile sites. Cancer Lett 232:4-12 (2006).
19. Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, et al: A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1:89-97 (2002).
20. Helmrich A, Stout-Weider K, Matthaei A, Hermann K, Heiden T, Schrock E: Identification of the human/mouse syntenic common fragile site FRA7K/Fra12C1 - relation of FRA7K and other human common fragile sites on chromosome 7 to evolutionary breakpoints. Int J Cancer 120:48-54 (2007).
21. Huang LW, Chao SL, Chen TJ: Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis. Gynecol Oncol 90:331-337 (2003).
22. Ingvarsson S: FHIT alterations in breast cancer. Semin Cancer Biol 11:361-366 (2001).
23. Ishii H, Furukawa Y: Alterations of common chromosome fragile sites in hematopoietic malignancies. Int J Hematol 79:238-242 (2004).
24. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, et al: Cancer statistics, 2004. CA Cancer J Clin 54:8-29 (2004).
25. Kademani D: Oral cancer. Mayo Clin Proc 82:878-887 (2007).
26. Krummel KA, Roberts LR, Kawakami M, Glover TW, Smith DI: The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations. Genomics 69:37-46 (2000).
27. Langbein S, Szakacs O, Wilhelm M, Sukosd F, Weber S, et al: Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab Invest 82:639-643 (2002).
28. Lee JI, Soria JC, Hassan K, Liu D, Tang X, et al: Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Cancer Res 61:837-841 (2001).
29. Llewellyn CD, Johnson NW, Warnakulasuriya KA: Risk factors for squamous cell carcinoma of the oral cavity in young people - a comprehensive literature review. Oral Oncol 37:401-418 (2001).
30. Mao L, Hong WK, Papadimitrakopoulou VA: Focus on head and neck cancer. Cancer Cell 5:311-316 (2004).
31. Matsuyama A, Croce CM, Huebner K: Common fragile genes. Eur J Histochem 48:29-36 (2004).
32. McAvoy S, Ganapathiraju SC, Ducharme-Smith AL, Pritchett JR, Kosari F, et al: Non-random inactivation of large common fragile site genes in different cancers. Cytogenet Genome Res 118:260-269 (2007a).
33. McAvoy S, Ganapathiraju S, Perez DS, James CD, Smith DI: DMD and IL1RAPL1 : two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors. Cytogenet Genome Res 119:196-203 (2007b).
34. McAvoy S, Zhu Y, Perez DS, James CD, Smith DI: Disabled-1 is a large common fragile site gene, inactivated in multiple cancers. Genes Chromosomes Cancer 47:165-174 (2008).
35. McKaig RG, Baric RS, Olshan AF: Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20:250-265 (1998).
36. Nunez MI, Rosen DG, Ludes-Meyers JH, Abba MC, Kil H, et al: WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer 5:64 (2005).
37. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, et al: WWOX : a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci USA 98:11417-11422 (2001).
38. Pelliccia F, Curatolo A, Limongi ZM, Bosco N, Rocchi A: Transcriptional profiling of genes at the human common fragile site FRA1H in tumor-derived cell lines. Cancer Genet Cytogenet 178:144-150 (2007).
39. Pluciennik E, Kusinska R, Potemski P, Kubiak R, Kordek R, Bednarek AK: WWOX - the FRA1 6D cancer gene: expression correlation with breast cancer progression and prognosis. Eur J Surg Oncol 32:153-157 (2006).
40. Reshmi SC, Huang X, Schoppy DW, Black RC, Saunders WS, et al: Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes Chromosomes Cancer 46:143-154 (2007).
41. Rocco A, Schandl L, Chen J, Wang H, Tulassay Z, et al: Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer. J Cancer Res Clin Oncol 129:84-88 (2003).
42. Rozier L, El-Achkar E, Apiou F, Debatisse M: Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer. Oncogene 23:6872-6880 (2004).
43. Savelyeva L, Sagulenko E, Schmitt JG, Schwab M: The neurobeachin gene spans the common fragile site FRA13A. Hum Genet 118:551-558 (2006).
44. Schantz SP, Yu GP: Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 128:268-274 (2002).
45. Shridhar V, Wang L, Rosati R, Paradee W, Shridhar R, et al: Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas. Oncogene 14:1269-1277 (1997).
46. Silverman S, Jr: Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 132 Suppl:7S-11S (2001).
47. Silverman S, Jr, Gorsky M: Epidemiologic and demographic update in oral cancer: California and national data - 1973 to 1985. J Am Dent Assoc 120:495-499 (1990).
48. Singh B, Bhaya M, Zimbler M, Stern J, Roland JT, et al: Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 20:1-7 (1998).
49. Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, et al: Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 94:13771-13776 (1997).
50. Smith DI, Huang H, Wang L: Common fragile sites and cancer (review). Int J Oncol 12:187-196 (1998).
51. Smith DI, Zhu Y, McAvoy S, Kuhn R: Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 232:48-57 (2006).
52. Smith DI, McAvoy S, Zhu Y, Perez DS: Large common fragile site genes and cancer. Semin Cancer Biol 17:31-41 (2007).
53. Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, et al: Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 64:3741-3747 (2004).
54. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, et al: Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol 42:3176-3184 (2004).
55. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, et al: The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 85:17-26 (1996).
56. Strome SE, Savva A, Brissett AE, Gostout BS, Lewis J, et al: Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 8:1093-1100 (2002).
57. Sutherland GR: Rare fragile sites. Cytogenet Genome Res 100:77-84 (2003).
58. Swango PA: Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent 56:309-318 (1996).
59. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, et al: FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 93:9770-9775 (1996).
60. Wang F, Denison S, Lai JP, Philips LA, Montoya D, et al: Parkin gene alterations in hepatocellular carcinoma. Genes Chromosomes Cancer 40:85-96 (2004).
61. Yendamuri S, Kuroki T, Trapasso F, Henry AC, Dumon KR, et al: WW domain containing oxidoreductase gene expression is altered in nonsmall cell lung cancer. Cancer Res 63:878-881 (2003).
62. Zhu Y, McAvoy S, Kuhn R, Smith DI: RORA, a large common fragile site gene, is involved in cellular stress response. Oncogene 25:2901-2908 (2006).
63. Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM, et al: Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res 57:1166-1170 (1997).
64. Zlotorynski E, Rahat A, Skaug J, Ben-Porat N, Ozeri E, et al: Molecular basis for expression of common and rare fragile sites. Mol Cell Biol 23:7143-7151 (2003).